Sarepta LGMD trials all hit by FDA hold amid newly surfaced safety concerns over gene therapy Fierce Biotech We are mothers of Duchenne patients. Recent setbacks with Sarepta must not stop progress statnews.com Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug Yahoo Finance Drugmaker Refuses F.D.A. Request to Pull Treatment Linked to Patient Deaths The New York Times …
Read More »